A comparison of Symbicort single inhaler and conventional best practice for the treatment of persistent asthma in adolescents and adults - a 26-week, randomised, open, parallel group multicentre study.

Trial Profile

A comparison of Symbicort single inhaler and conventional best practice for the treatment of persistent asthma in adolescents and adults - a 26-week, randomised, open, parallel group multicentre study.

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Jan 2011

At a glance

  • Drugs Budesonide/formoterol (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms SYMPHONIE
  • Sponsors AstraZeneca
  • Most Recent Events

    • 05 Dec 2006 Status change
    • 29 Mar 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top